QuidelOrtho Q3 GAAP net loss $20M ($0.30 EPS); revenue $727M; reinstates 2024 guidance

QuidelOrtho Corp

2024-Q3 EPS reported -$27.92 revenue$2,075,100,000

Revenue $727M vs $744M YoY; Labs revenue grew 4% as reported (5% constant currency).
GAAP net loss $20M ($0.30 diluted EPS) vs loss $13M ($0.19) prior year; GAAP operating margin 2%.
Adjusted EBITDA margin 23.5%, up 80 bps; GAAP operating expenses down $13M to $242M.
Company reinstated 2024 financial guidance after withdrawing prior outlook.
Integration-related charges of $37M; new CTO and CHRO appointed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.